Abstract:Vipul Vilas Wagh, 1 Tanvi Kottat, 1 Suchita Agrawal, 2 Shruti Purohit, 2 Tejaswini Arun Pachpor, 3, 4 Leelavati Narlikar, 5 Vasudeo Paralikar, 2 Satyajeet Pramod Khare 1 1 Symbiosis School of Biological Sciences, Symbiosis International (Deemed University), Pune, MH, India; 2 Psychiatry Unit, KEM Hospital Research Centre, Pune, MH, India; 3 Department of Biosciences and Technology, School of Science and Environment Studies, Dr. Vishwanath Karad MIT World Peace University, Pune, MH, India; 4 Department of Biotechnology, MES Abasaheb Garware College, Pune, MH, India; 5 Department of Data Science, Indian Institute of Science Education and Research, Pune, MH, India Correspondence: Vasudeo Paralikar; Satyajeet Pramod Khare, Email ; Introduction: Stigma contributes to a significant part of the burden of schizophrenia (SCZ), therefore reducing false positives from the diagnosis would be liberating for the individuals with SCZ and desirable for the clinicians. The stigmatization associated with schizophrenia advocates the need for high-precision diagnosis. In this study, we present an ensemble learning-based approach for high-precision diagnosis of SCZ using peripheral blood gene expression profiles. Methodology: The machine learning (ML) models, support vector machines (SVM), and prediction analysis for microarrays (PAM) were developed using differentially expressed genes (DEGs) as features. The SCZ samples were classified based on a voting ensemble classifier of SVM and PAM. Further, microarray-based learning was used to classify RNA sequencing (RNA-Seq) samples from our case-control study (Pune-SCZ) to assess cross-platform compatibility. Results: Ensemble learning using ML models resulted in a significantly higher precision of 80.41% (SD: 0.04) when compared to the individual models (SVM-radial: 71.69%, SD: 0.04 and PAM 77.20%, SD: 0.02). The RNA sequencing samples from our case-control study (Pune-SCZ) resulted in a moderate precision (59.92%, SD: 0.05). The feature genes used for model building were enriched for biological processes such as response to stress, regulation of the immune system, and metabolism of organic nitrogen compounds. The network analysis identified RBX1, CUL4B, DDB1, PRPF19 , and COPS4 as hub genes. Conclusion: In summary, this study developed robust models for higher diagnostic precision in psychiatric disorders. Future efforts will be directed towards multi-omic integration and developing "explainable" diagnostic models. Keywords: Schizophrenia, peripheral blood, gene expression, machine learning, ensemble learning Graphical Schizophrenia (SCZ) is a complex neuropsychiatric disorder characterized by a disruption in thinking and sense of self. The death rate is two times higher in schizophrenia-affected individuals, with cardiovascular diseases and suicide as the leading causes of death. 1–3 The global burden of disease 2019 estimates that almost 24 million people are affected by SCZ globally, which indicates its universal presence irrespective of cultural differences worldwide. 4 Significant issues in treating psychiatric disorders are delayed diagnosis and limited certainty of the diagnosis itself. The current diagnostic procedure for SCZ is based on psychiatric evaluation, making it clinician-dependent. The Diagnostic and Statistical Manual of Mental Disorders (DSM-5) based diagnosis for SCZ requires symptoms to be persistent for six months or more. 5 The delay in the treatment accounts for a higher number of years lived with disability associated with SCZ. 6 Recent studies suggest that treatment outcomes can be improved if the time elapsed before the treatment is reduced. 7 Thus, having a sensitive and specific blood test can strengthen and hasten the current diagnostic process for SCZ. Cellular alterations, such as gene expression changes associated with the disorder, have been proposed to be useful as potential biomarkers. A previous study provides substantial evidence for using peripheral blood gene expression profiles for biomarker discovery. 8 The recent use of machine learning (ML) tools has accelerated the biomarker discovery process for psychiatric disorders. 9–11 ML models employ statistical methods to learn from the data to achieve specific objectives. Support vector machines (SVM) and nearest shrunken centroids (NSC) are popular examples of supervised learning ML algorithms used in genomics, particularly in transcriptomics. 12 The ML tools have already provided gene expression markers with higher diagnostic potential. 9,10,13 -Abstract Truncated-

Ensemble Learning for Higher Diagnostic Precision in Schizophrenia Using Peripheral Blood Gene Expression Profile

The Correlation-Base-Selection Algorithm for Diagnostic Schizophrenia Based on Blood-Based Gene Expression Signatures.

Integrated Transcriptome Analysis Reveals Novel Molecular Signatures for Schizophrenia Characterization.

Precision medicine for psychotic disorders: objective assessment, risk prediction, and pharmacogenomics

Role of different omics data in the diagnosis of schizophrenia disorder: A machine learning study

Identification of hub genes and construction of diagnostic nomogram model in schizophrenia

Identification of differentially expressed genes of blood leukocytes for Schizophrenia

Identification of Immune-Related Biomarkers of Schizophrenia in the Central Nervous System Using Bioinformatic Methods and Machine Learning Algorithms

Schizophrenia Biomarkers: Blood Transcriptome Suggests Two Molecular Subtypes

Identification of immune-related biomarkers in peripheral blood of schizophrenia using bioinformatic methods and machine learning algorithms

Machine learning techniques in a structural and functional MRI diagnostic approach in schizophrenia: a systematic review

Detecting outliers in case-control cohorts for improving deep learning networks on Schizophrenia prediction

Gene expression in patient-derived neural progenitors provide insights into neurodevelopmental aspects of schizophrenia

Identification of important gene signatures in schizophrenia through feature fusion and genetic algorithm

Advanced Signal Processing Methods for Characterization of Schizophrenia

Consistent Gene Signature of Schizophrenia Identified by a Novel Feature Selection Strategy from Comprehensive Sets of Transcriptomic Data

A diagnostic model based on bioinformatics and machine learning to differentiate bipolar disorder from schizophrenia and major depressive disorder

A machine learning case–control classifier for schizophrenia based on DNA methylation in blood

Functional analysis of schizophrenia genes using GeneAnalytics program and integrated databases

Schizophrenia and cell senescence candidate genes screening, machine learning, diagnostic models, and drug prediction

Unveiling the potential of machine learning in schizophrenia diagnosis: A meta-analytic study of task-based neuroimaging data